News
The European Commission, Directorate-General for Education, Youth, Sport and Culture (DG EAC) has shared communication material designed to help more businesses discover how they can improve their research and innovation capabilities through the Marie Skłodowska-Curie Actions (MSCA). It is available both as a webpage and as downloadable files for both print and web use (a guide, slides and visuals). The MSCA Guide for Businesses is designed to explain, in simple terms, why companies should engage with MSCA and the different ways they can get involved. The material refers to two testimonies from companies that were involved in MSCA-funded Staff Exchanges projects:
The communication material was developed to reach new businesses and strengthen the links between academia and non-academia across Europe.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
The network of National Contact Points (NCPs) for the European Research Council (ERC), mERCury, has recently published the first edition of the ERC Success Stories from Widening countries. The collection features seven ERC grantees from Malta, Croatia, Romania, Slovenia, Latvia, Greece and Türkiye who have received Starting, Consolidator,...
Read moreThe selected projects of the 2026 European Research Council (ERC) Synergy Grant call (call deadline 5 November 2025) were published by the ERC Executive Agency. Synergy grant projects consist of minimum two to maximum four researchers or Principal Investigators (PIs) and their teams that jointly address ambitious research problems that could...
Read moreThe new European Partnership for Resilient Cultural Heritage (RCH) that kicked off at the end of September has launched its first Joint Transnational Call (JTC): "Foundations for climate-resilient cultural heritage: Assessing and managing impact and risk, dealing with damage and loss". This first call within the RCH Partnership invites research...
Read moreNCP_WIDERA.NET, the WIDERA National Contact Points network, has so far put six projects, funded under the ERA part of the Horizon Europe WIDERA or Horizon 2020 Science with and for Society (Swafs) work programmes, in the spotlight in their ERA Success Stories series. The latest project example is COALESCE Advancing Leadership and Engagement in...
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
